Presenting companies announced for major investment summit

By AusBiotech
Thursday, 20 September, 2012

The Australasian Life Science Investment Summit 2012, the largest investment event of its kind in the Southern Hemisphere will again be held in conjunction with Australia’s premier biotechnology industry conference, AusBiotech 2012. Companies selected to present at the event have been announced.

The event features 40 investment pitching presentations from Australasia’s most promising life science companies, in one place on one day. Registration is free for bona fide investors only and places are limited for the Summit to be held at the Melbourne Convention Centre on Friday 2 November.

The Summit will commence from 9:00am and concludes with a networking reception finishing at 5:30pm. AusBiotech is pleased to announce the presenting companies, which include:

Acrux
Agenix Limited
Allied Healthcare Group
Benitec Biopharma
BioDiem
Bionomics
Biotron
Bluechiip Limited
Broadvector Limited
CBIO
Cellmid Limited
Circadian Technologies
Clarity Pharmaceuticals
Consegna Group
Elastagen
Genetic Technologies
Global Kinetics Corporation
Hatchtech
Living Cell Technologies
Minomic International
Nanosonics
Neuren Pharmaceuticals
Nextgen Plants
Nextvet Biopharma
Optiscan Imaging
Osprey Medical
Phosphagenics
Phylogica
Prana Biotechnology
pSivida
QRX Pharma
Spinifex Pharmaceuticals
Starpharma
Sunshine Heart
Tissue Therapies
Ultraceuticals
Xenexus Pharmaceuticals

For further details please contact AusBiotech’s Investment Program Manager, Hayley Laing on or +61 3 9828 1400. Information is also available at the ALSIS 2012 event website.